The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
Blog |
Trust, transparency and purpose – managing reputation in a challenging environment
News |
ABPI comment on UK-US trade agreement
News |
Life sciences growth requires payment rates to return to internationally comparable levels
News |
UK-India trade agreement does not support UK life sciences ambitions, says ABPI
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
Online Workshop on SMC: How to prepare and submit to SMC | 09 - 10 June 2025
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
PMCPA Code of Practice Seminar - 10 June 2025
The training will cover the requirements of the Code of Practice and procedures followed by the PMCPA, the Code of Practice Panel and the Code of Practice Appeal Board.
PMCPA Code of Practice Seminar - 11 June 2025
The training will cover the requirements of the Code of Practice and procedures followed by the PMCPA, the Code of Practice Panel and the Code of Practice Appeal Board.
NICE/DSU/ABPI Masterclass: Optimising NICE submissions in oncology
NICE and the ABPI invite you to the second event in the NICE/DSU/ABPI Masterclass Programme for 2025 - Optimising NICE submissions in oncology.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]